These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 34052506

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Early Post-Transplantation Serum Ferritin Level Predicts Survival in Recipients of Haploidentical Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis.
    Jullien M, Orvain C, Berceanu A, Couturier MA, Guillaume T, Peterlin P, Garnier A, Bourgeois AL, Klemencie M, Schmidt A, Hunault M, Daguindau E, Roussel X, Delepine P, Guillerm G, Giltat A, François S, Thepot S, Gouill SL, Béné MC, Chevallier P.
    Transplant Cell Ther; 2021 Oct; 27(10):861.e1-861.e7. PubMed ID: 34245928
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Determining Whether Prophylactic Antiviral Treatment Is Necessary in HBsAg-Negative/HBcAb-Positive Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhang A, Wu Y, Tan Y, Shi J, Zhao Y, Hu Y, Yu J, Zheng W, Lai X, Zhang M, Zhu Y, Ye Y, Huang Y, Fu S, Huang H, Luo Y.
    Biol Blood Marrow Transplant; 2020 May; 26(5):956-964. PubMed ID: 31962163
    [Abstract] [Full Text] [Related]

  • 6. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
    Liao YP, Jiang JL, Zou WY, Xu DR, Li J.
    World J Gastroenterol; 2015 Apr 14; 21(14):4284-92. PubMed ID: 25892880
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for cytomegalovirus DNAemia following haploidentical stem cell transplantation and its association with host hepatitis B virus serostatus.
    Chen Y, Xu LP, Liu KY, Chen H, Chen YH, Zhang XH, Wang Y, Wang FR, Han W, Wang JZ, Yan CH, Huang XJ.
    J Clin Virol; 2016 Feb 14; 75():10-5. PubMed ID: 26735213
    [Abstract] [Full Text] [Related]

  • 8. Allogeneic hematopoietic stem cell transplantation: A single-center experience, 2017 to 2021.
    da Silva PCL, Muzzi GC, Vilela MR, Fabreti-Oliveira RA.
    Transpl Immunol; 2024 Feb 14; 82():101989. PubMed ID: 38199270
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of ATG-thymoglobulin with ATG-Fresenius for Epstein-Barr virus infections and graft-versus-host-disease in patients with hematological malignances after haploidentical hematopoietic stem cell transplantation: a single-center experience.
    Zhou L, Gao ZY, Lu DP.
    Ann Hematol; 2020 Jun 14; 99(6):1389-1400. PubMed ID: 32291495
    [Abstract] [Full Text] [Related]

  • 13. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
    Lei M, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Wu H, Xu MQ, Chen ZY, Wei YG.
    World J Gastroenterol; 2018 Dec 28; 24(48):5525-5536. PubMed ID: 30622380
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An Examination of Cytomegalovirus, Socioeconomic Status, Race, and Ethnicity on Outcomes after Haploidentical Hematopoietic Transplantation.
    Jeurkar C, Leiby B, Banks J, Leader A, Rudolph S, Mateja G, Rashid SA, Carabasi M, Filicko-O'Hara J, O'Hara W, Wagner JL, Gergis U, Flomenberg N, Grosso D.
    Transplant Cell Ther; 2021 Apr 28; 27(4):327.e1-327.e11. PubMed ID: 33836876
    [Abstract] [Full Text] [Related]

  • 16. [The influence of hepatitis B virus infection on patients undergoing allogeneic hematopoietic stem cell transplantation].
    Liang C, Jiang EL, Huang Y, Yan ZS, Yang DL, He Y, Ma QL, Wei JL, Wang M, Feng SZ, Qiu LG, Han MZ.
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jul 28; 31(7):456-60. PubMed ID: 21122399
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis B Virus Vaccination after Allogeneic Hematopoietic Cell Transplantation Prevents Post-Transplantation Hepatitis B Virus Reactivation.
    Hammond SP, Ho VT, Marty FM.
    Transplant Cell Ther; 2022 Jul 28; 28(7):402.e1-402.e5. PubMed ID: 35413458
    [Abstract] [Full Text] [Related]

  • 18. A Novel Strategy for the Prevention of Hepatitis B Virus-Related Hepatitis Following Allogeneic Hematopoietic Stem Cell Transplantation from Hepatitis B Surface Antigen-Positive Donors.
    Wu Y, Shi J, Tan Y, Zhao Y, Yu J, Lai X, Yang L, Huang H, Luo Y.
    Biol Blood Marrow Transplant; 2020 Sep 28; 26(9):1719-1728. PubMed ID: 32434055
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome.
    Mikulska M, Nicolini L, Signori A, Rivoli G, Del Bono V, Raiola AM, Di Grazia C, Dominietto A, Varaldo R, Ghiso A, Bacigalupo A, Viscoli C.
    Clin Microbiol Infect; 2014 Oct 28; 20(10):O694-701. PubMed ID: 24575948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.